ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Vanda Pharmaceuticals Closes Enrollment In The ODYSSEY Study Comparing Tradipitant And Placebo In Hospitalized COVID-19 Pneumonia Patients
August 04, 2021Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that enrollment has closed in the ODYSSEY study comparing tradipitant and placebo in hospitalized COVID-19 pneumonia patients. -
Vanda Announces Positive Study Results for Hetlioz
December 11, 2018Vanda announced Hetlioz (tasimelteon) improved sleep quality and increased sleep duration in patients with Smith-Magenis Syndrome (SMS) in a pivotal placebo controlled clinical study.... -
Vanda Announces Positive Phase II Study Results for Tradipitant
December 04, 2018Vanda Pharmaceuticals announced tradipitant met the primary endpoint in VLY686-2301, a Phase II clinical study in patients with idiopathic and diabetic gastroparesis......
Pharma Sources Insight January 2025
